Information:
Error:
ID
34324
Description
Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience; ODM derived from: https://clinicaltrials.gov/show/NCT02485262
Link
https://clinicaltrials.gov/show/NCT02485262
Keywords
Versions (1)
- 1/16/19 1/16/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 16, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hepatitis C NCT02485262
Eligibility Hepatitis C NCT02485262
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C NCT02485262
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
adult chronic hcv patients aged >18
boolean
ID.2
Item
treatment naïve
boolean
ID.3
Item
patient with cirrhosis and no cirrhosis. cirrhosis defined as stage 4 fibrosis on liver biopsy or fibro sure results indicating cirrhosis or has clinical findings suggestive of cirrhosis
boolean
ID.4
Item
patients meet the indication to receive one of the sof treatment based regimens
boolean
ID.5
Item
co-infected patients with hiv or hepatitis b
boolean
ID.6
Item
patient received one of the daas regimens
boolean
ID.7
Item
patient with active substance abuse and alcohol abuse
boolean
ID.8
Item
patient received prior daa regimen
boolean
ID.9
Item
decompensated cirrhotic patients
boolean
ID.10
Item
patient has contraindication to receive sof
boolean